NCT00006452View on ClinicalTrials.gov

Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 10, 2002

Primary Completion Date

May 9, 2003

Study Completion Date

March 16, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

motexafin gadolinium

RADIATION

radiation therapy

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00006452 - Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter